{"id":18605,"date":"2026-06-18T13:45:22","date_gmt":"2026-06-18T12:45:22","guid":{"rendered":"https:\/\/fmc.millywilly.website\/?p=18605"},"modified":"2026-06-18T13:46:20","modified_gmt":"2026-06-18T12:46:20","slug":"medicaments-potentiellement-inadaptes-chez-les-personnes-agees-en-suisse","status":"publish","type":"post","link":"https:\/\/fmc.millywilly.website\/fr\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/","title":{"rendered":"Traitements m\u00e9dicamenteux potentiellement inadapt\u00e9s chez les personnes \u00e2g\u00e9es en Suisse : fr\u00e9quence, risque d'hospitalisation et co\u00fbts de sant\u00e9"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"18605\" class=\"elementor elementor-18605\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-062316f e-flex e-con-boxed e-con e-parent\" data-id=\"062316f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-76acd7a elementor-widget elementor-widget-text-editor\" data-id=\"76acd7a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>L'\u00e9tude de Farcher et al. examine pour la premi\u00e8re fois \u00e0 l'\u00e9chelle nationale la pr\u00e9valence des m\u00e9dicaments potentiellement inappropri\u00e9s (Potentially Inappropriate Medications, PIM) chez les personnes \u00e2g\u00e9es de 65 ans et plus en Suisse, ainsi que leurs r\u00e9percussions sur les hospitalisations et les co\u00fbts de sant\u00e9. L'analyse s'appuie sur les donn\u00e9es de routine d'une grande caisse d'assurance maladie suisse. L'\u00e9valuation des m\u00e9dicaments a \u00e9t\u00e9 r\u00e9alis\u00e9e selon des crit\u00e8res internationaux \u00e9tablis (crit\u00e8res de Beers et liste PRISCUS).<\/p>\n<p>Les r\u00e9sultats montrent qu\u2019en 2022, environ un tiers de la population suisse \u00e2g\u00e9e de 65 ans et plus s\u2019est vu prescrire au moins un m\u00e9dicament potentiellement inadapt\u00e9. La p\u00e9riode suivant imm\u00e9diatement la prescription est particuli\u00e8rement critique : le risque d\u2019hospitalisation \u00e9tait pr\u00e8s de trois fois plus \u00e9lev\u00e9 au cours des 15 premiers jours suivant la prescription d\u2019un m\u00e9dicament potentiellement inadapt\u00e9 (PIM) que chez des personnes comparables ne prenant pas ce type de m\u00e9dicaments. Bien que ce risque ait diminu\u00e9 par la suite, il restait encore nettement plus \u00e9lev\u00e9, m\u00eame apr\u00e8s un an. De plus, les personnes ayant re\u00e7u une prescription de PIM ont g\u00e9n\u00e9r\u00e9 en moyenne environ 3 200 francs de frais de sant\u00e9 suppl\u00e9mentaires par an par rapport aux personnes ne prenant pas ce type de m\u00e9dicaments. L\u2019\u00e9tude souligne par ailleurs qu\u2019une grande partie des prescriptions potentiellement inappropri\u00e9es se concentre sur quelques groupes de m\u00e9dicaments, notamment les analg\u00e9siques (en particulier les AINS), les inhibiteurs de la pompe \u00e0 protons, les benzodiaz\u00e9pines et les somnif\u00e8res de type benzodiaz\u00e9pine, ainsi que certains psychotropes. Cela ouvre des pistes concr\u00e8tes pour des bilans th\u00e9rapeutiques structur\u00e9s et d\u2019autres mesures visant \u00e0 am\u00e9liorer la s\u00e9curit\u00e9 des traitements m\u00e9dicamenteux.<\/p>\n<p>Les auteurs attribuent ces causes, entre autres, \u00e0 la multimorbidit\u00e9 croissante des personnes \u00e2g\u00e9es, \u00e0 la complexit\u00e9 des recommandations th\u00e9rapeutiques ainsi qu\u2019aux difficult\u00e9s li\u00e9es \u00e0 la coordination des diff\u00e9rents traitements. Cette \u00e9tude montre clairement que la s\u00e9curit\u00e9 des traitements m\u00e9dicamenteux est une condition essentielle \u00e0 la qualit\u00e9 des soins prodigu\u00e9s aux personnes \u00e2g\u00e9es. Elle souligne l\u2019importance des bilans m\u00e9dicamenteux syst\u00e9matiques et d\u2019une collaboration \u00e9troite entre m\u00e9decins g\u00e9n\u00e9ralistes, sp\u00e9cialistes, pharmacies, h\u00f4pitaux et autres professionnels de sant\u00e9.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d9a995e elementor-widget elementor-widget-shortcode\" data-id=\"d9a995e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\"><div class=\"_df_book df-lite\" id=\"df_18603\"  _slug=\"artikel-und-studien_potenziell-inadaequate-medikation-bei-aelteren-menschen\" data-title=\"artikel-und-studien_potenziell-inadaequate-medikation-bei-aelteren-menschen\" wpoptions=\"true\" thumbtype=\"\" ><\/div><script class=\"df-shortcode-script\" nowprocket type=\"application\/javascript\">window.option_df_18603 = {\"outline\":[],\"backgroundColor\":\"#f1f1f1\",\"height\":\"700\",\"autoEnableOutline\":\"false\",\"autoEnableThumbnail\":\"false\",\"overwritePDFOutline\":\"false\",\"direction\":\"1\",\"pageSize\":\"0\",\"source\":\"https:\\\/\\\/fmc.millywilly.website\\\/http:\\\/\\\/fmc.millywilly.website\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.pdf\",\"wpOptions\":\"true\"}; if(window.DFLIP && window.DFLIP.parseBooks){window.DFLIP.parseBooks();}<\/script><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Cette \u00e9tude examine pour la premi\u00e8re fois la pr\u00e9valence des traitements m\u00e9dicamenteux potentiellement inadapt\u00e9s chez les personnes \u00e2g\u00e9es de 65 ans et plus en Suisse, ainsi que leurs r\u00e9percussions sur les hospitalisations et les co\u00fbts de sant\u00e9.<\/p>","protected":false},"author":2,"featured_media":18601,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":[149,139],"meta":{"footnotes":""},"strategie":[157],"thema":[169],"class_list":["post-18605","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","strategie-instrumente","thema-population-health","format-artikel-und-studien","format-publikation"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten - FMC<\/title>\n<meta name=\"description\" content=\"Die Studie untersucht erstmals die Verbreitung potenziell inad\u00e4quater Medikamente bei Menschen ab 65 Jahren in der Schweiz sowie deren Auswirkungen auf Spitaleintritte und Gesundheitskosten.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fmc.millywilly.website\/fr\/medicaments-potentiellement-inadaptes-chez-les-personnes-agees-en-suisse\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten - FMC\" \/>\n<meta property=\"og:description\" content=\"Die Studie untersucht erstmals die Verbreitung potenziell inad\u00e4quater Medikamente bei Menschen ab 65 Jahren in der Schweiz sowie deren Auswirkungen auf Spitaleintritte und Gesundheitskosten.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fmc.millywilly.website\/fr\/medicaments-potentiellement-inadaptes-chez-les-personnes-agees-en-suisse\/\" \/>\n<meta property=\"og:site_name\" content=\"FMC\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-18T12:45:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-18T12:46:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fmc.millywilly.website\/http:\/\/fmc.millywilly.website\/wp-content\/uploads\/2026\/06\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png\" \/>\n\t<meta property=\"og:image:width\" content=\"582\" \/>\n\t<meta property=\"og:image:height\" content=\"542\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nadja Blanchard\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nadja Blanchard\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/\"},\"author\":{\"name\":\"Nadja Blanchard\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#\\\/schema\\\/person\\\/51b0a56ce6ea20428517e39fd33e4f12\"},\"headline\":\"Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten\",\"datePublished\":\"2026-06-18T12:45:22+00:00\",\"dateModified\":\"2026-06-18T12:46:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/\"},\"wordCount\":284,\"publisher\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fmc.millywilly.website\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png\",\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/\",\"url\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/\",\"name\":\"Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten - FMC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fmc.millywilly.website\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png\",\"datePublished\":\"2026-06-18T12:45:22+00:00\",\"dateModified\":\"2026-06-18T12:46:20+00:00\",\"description\":\"Die Studie untersucht erstmals die Verbreitung potenziell inad\u00e4quater Medikamente bei Menschen ab 65 Jahren in der Schweiz sowie deren Auswirkungen auf Spitaleintritte und Gesundheitskosten.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fmc.millywilly.website\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png\",\"contentUrl\":\"https:\\\/\\\/fmc.millywilly.website\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png\",\"width\":582,\"height\":542},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fmc.millywilly.website\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#website\",\"url\":\"https:\\\/\\\/fmc.millywilly.website\\\/\",\"name\":\"FMC\",\"description\":\"Schweizer Forum f\u00fcr Integrierte Versorgung\",\"publisher\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fmc.millywilly.website\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#organization\",\"name\":\"FMC\",\"url\":\"https:\\\/\\\/fmc.millywilly.website\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fmc.millywilly.website\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/fmc-logo.svg\",\"contentUrl\":\"https:\\\/\\\/fmc.millywilly.website\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/fmc-logo.svg\",\"caption\":\"FMC\"},\"image\":{\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fmc.millywilly.website\\\/#\\\/schema\\\/person\\\/51b0a56ce6ea20428517e39fd33e4f12\",\"name\":\"Nadja Blanchard\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/729fbcebbfccd7834565b1398470d6ea84a4f3e7525873a0cb368db99228ce7b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/729fbcebbfccd7834565b1398470d6ea84a4f3e7525873a0cb368db99228ce7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/729fbcebbfccd7834565b1398470d6ea84a4f3e7525873a0cb368db99228ce7b?s=96&d=mm&r=g\",\"caption\":\"Nadja Blanchard\"},\"url\":\"https:\\\/\\\/fmc.millywilly.website\\\/fr\\\/author\\\/nadja-blanchardfmc-ch\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Traitements m\u00e9dicamenteux potentiellement inadapt\u00e9s chez les personnes \u00e2g\u00e9es en Suisse : fr\u00e9quence, risque d'hospitalisation et co\u00fbts de sant\u00e9 - FMC","description":"Cette \u00e9tude examine pour la premi\u00e8re fois la pr\u00e9valence des traitements m\u00e9dicamenteux potentiellement inadapt\u00e9s chez les personnes \u00e2g\u00e9es de 65 ans et plus en Suisse, ainsi que leurs r\u00e9percussions sur les hospitalisations et les co\u00fbts de sant\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fmc.millywilly.website\/fr\/medicaments-potentiellement-inadaptes-chez-les-personnes-agees-en-suisse\/","og_locale":"fr_FR","og_type":"article","og_title":"Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten - FMC","og_description":"Die Studie untersucht erstmals die Verbreitung potenziell inad\u00e4quater Medikamente bei Menschen ab 65 Jahren in der Schweiz sowie deren Auswirkungen auf Spitaleintritte und Gesundheitskosten.","og_url":"https:\/\/fmc.millywilly.website\/fr\/medicaments-potentiellement-inadaptes-chez-les-personnes-agees-en-suisse\/","og_site_name":"FMC","article_published_time":"2026-06-18T12:45:22+00:00","article_modified_time":"2026-06-18T12:46:20+00:00","og_image":[{"width":582,"height":542,"url":"https:\/\/fmc.millywilly.website\/http:\/\/fmc.millywilly.website\/wp-content\/uploads\/2026\/06\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png","type":"image\/png"}],"author":"Nadja Blanchard","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Nadja Blanchard","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/#article","isPartOf":{"@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/"},"author":{"name":"Nadja Blanchard","@id":"https:\/\/fmc.millywilly.website\/#\/schema\/person\/51b0a56ce6ea20428517e39fd33e4f12"},"headline":"Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten","datePublished":"2026-06-18T12:45:22+00:00","dateModified":"2026-06-18T12:46:20+00:00","mainEntityOfPage":{"@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/"},"wordCount":284,"publisher":{"@id":"https:\/\/fmc.millywilly.website\/#organization"},"image":{"@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/#primaryimage"},"thumbnailUrl":"https:\/\/fmc.millywilly.website\/wp-content\/uploads\/2026\/06\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png","inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/","url":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/","name":"Traitements m\u00e9dicamenteux potentiellement inadapt\u00e9s chez les personnes \u00e2g\u00e9es en Suisse : fr\u00e9quence, risque d'hospitalisation et co\u00fbts de sant\u00e9 - FMC","isPartOf":{"@id":"https:\/\/fmc.millywilly.website\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/#primaryimage"},"image":{"@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/#primaryimage"},"thumbnailUrl":"https:\/\/fmc.millywilly.website\/wp-content\/uploads\/2026\/06\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png","datePublished":"2026-06-18T12:45:22+00:00","dateModified":"2026-06-18T12:46:20+00:00","description":"Cette \u00e9tude examine pour la premi\u00e8re fois la pr\u00e9valence des traitements m\u00e9dicamenteux potentiellement inadapt\u00e9s chez les personnes \u00e2g\u00e9es de 65 ans et plus en Suisse, ainsi que leurs r\u00e9percussions sur les hospitalisations et les co\u00fbts de sant\u00e9.","breadcrumb":{"@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/#primaryimage","url":"https:\/\/fmc.millywilly.website\/wp-content\/uploads\/2026\/06\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png","contentUrl":"https:\/\/fmc.millywilly.website\/wp-content\/uploads\/2026\/06\/Artikel-und-Studien_Potenziell-inadaequate-Medikation-bei-aelteren-Menschen.png","width":582,"height":542},{"@type":"BreadcrumbList","@id":"https:\/\/fmc.millywilly.website\/potenziell-inadaequate-medikation-bei-aelteren-menschen-in-der-schweiz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fmc.millywilly.website\/"},{"@type":"ListItem","position":2,"name":"Potenziell inad\u00e4quate Medikation bei \u00e4lteren Menschen in der Schweiz: H\u00e4ufigkeit, Hospitalisationsrisiko und Gesundheitskosten"}]},{"@type":"WebSite","@id":"https:\/\/fmc.millywilly.website\/#website","url":"https:\/\/fmc.millywilly.website\/","name":"FMC","description":"Forum suisse des soins int\u00e9gr\u00e9s","publisher":{"@id":"https:\/\/fmc.millywilly.website\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fmc.millywilly.website\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/fmc.millywilly.website\/#organization","name":"FMC","url":"https:\/\/fmc.millywilly.website\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/fmc.millywilly.website\/#\/schema\/logo\/image\/","url":"https:\/\/fmc.millywilly.website\/wp-content\/uploads\/2023\/09\/fmc-logo.svg","contentUrl":"https:\/\/fmc.millywilly.website\/wp-content\/uploads\/2023\/09\/fmc-logo.svg","caption":"FMC"},"image":{"@id":"https:\/\/fmc.millywilly.website\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fmc.millywilly.website\/#\/schema\/person\/51b0a56ce6ea20428517e39fd33e4f12","name":"Nadja Blanchard","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/729fbcebbfccd7834565b1398470d6ea84a4f3e7525873a0cb368db99228ce7b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/729fbcebbfccd7834565b1398470d6ea84a4f3e7525873a0cb368db99228ce7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/729fbcebbfccd7834565b1398470d6ea84a4f3e7525873a0cb368db99228ce7b?s=96&d=mm&r=g","caption":"Nadja Blanchard"},"url":"https:\/\/fmc.millywilly.website\/fr\/author\/nadja-blanchardfmc-ch\/"}]}},"_links":{"self":[{"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/posts\/18605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/comments?post=18605"}],"version-history":[{"count":4,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/posts\/18605\/revisions"}],"predecessor-version":[{"id":18609,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/posts\/18605\/revisions\/18609"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/media\/18601"}],"wp:attachment":[{"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/media?parent=18605"}],"wp:term":[{"taxonomy":"strategie","embeddable":true,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/strategie?post=18605"},{"taxonomy":"thema","embeddable":true,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/thema?post=18605"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/fmc.millywilly.website\/fr\/wp-json\/wp\/v2\/format?post=18605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}